In the current study, we first identified that the elder was an independent prognostic factor for better PFS in the patients treated with a first-line EGFR TKI for their stage IV lung adenocarcinoma harboring uncommon mutation. This evidence concerns the gene EGFR and lung adenocarcinoma.